×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ALXO – alx oncology holdings inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ALXO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/18
11:14 am
alxo
ALX Oncology to Present at Upcoming Investor Conferences [Yahoo! Finance]
Medium
Report
ALX Oncology to Present at Upcoming Investor Conferences [Yahoo! Finance]
11/18
11:00 am
alxo
ALX Oncology to Present at Upcoming Investor Conferences
Medium
Report
ALX Oncology to Present at Upcoming Investor Conferences
11/13
09:53 am
alxo
ALX Oncology (NASDAQ:ALXO) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $4.00 price target on the stock.
Low
Report
ALX Oncology (NASDAQ:ALXO) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $4.00 price target on the stock.
11/8
07:05 pm
alxo
ALX Oncology Holdings Inc (ALXO) Q3 2025 Earnings Call Highlights: Promising Clinical Advances ... [Yahoo! Finance]
Low
Report
ALX Oncology Holdings Inc (ALXO) Q3 2025 Earnings Call Highlights: Promising Clinical Advances ... [Yahoo! Finance]
11/7
08:15 am
alxo
ALX Oncology Reports Third Quarter 2025 Financial Results and Provides Corporate Update
High
Report
ALX Oncology Reports Third Quarter 2025 Financial Results and Provides Corporate Update
10/30
08:30 am
alxo
ALX Oncology to Report Third Quarter 2025 Financial Results and Pipeline Progress Including Evorpacept CD47 Biomarker Data to be Presented at Upcoming SITC Annual Meeting
Medium
Report
ALX Oncology to Report Third Quarter 2025 Financial Results and Pipeline Progress Including Evorpacept CD47 Biomarker Data to be Presented at Upcoming SITC Annual Meeting
10/23
12:30 pm
alxo
ALX Oncology Announces Preclinical Data and Phase 1 Trial-in-Progress Presentations of ALX2004, a Novel EGFR-Targeted ADC, at 2025 AACR-NCI-EORTC Conference
Low
Report
ALX Oncology Announces Preclinical Data and Phase 1 Trial-in-Progress Presentations of ALX2004, a Novel EGFR-Targeted ADC, at 2025 AACR-NCI-EORTC Conference
10/3
09:45 am
alxo
ALX Oncology to Present Updated Data from Phase 2 ASPEN-06 Trial, Highlighting CD47 Expression as a Predictive Biomarker in HER2+ Gastric Cancer, at 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting [Yahoo! Finance]
Medium
Report
ALX Oncology to Present Updated Data from Phase 2 ASPEN-06 Trial, Highlighting CD47 Expression as a Predictive Biomarker in HER2+ Gastric Cancer, at 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
11/7/2025
08:15 am
alxo
alx oncology holdings inc.
MISS
Report
15.0%
alx oncology holdings inc.
8/12/2025
04:05 pm
alxo
alx oncology holdings inc.
MISS
Report
8.7%
alx oncology holdings inc.
5/8/2025
08:30 am
alxo
alx oncology holdings inc.
MISS
Report
-2.1%
alx oncology holdings inc.
3/6/2025
04:01 pm
alxo
alx oncology holdings inc.
BEAT
Report
-17.2%
alx oncology holdings inc.
Date
Time
Symbol
Headline
Impact
11/14
04:23 pm
alxo
Form SCHEDULE 13G/A ALX ONCOLOGY HOLDINGS Filed by: TANG CAPITAL MANAGEMENT LLC
High
Report
Form SCHEDULE 13G/A ALX ONCOLOGY HOLDINGS Filed by: TANG CAPITAL MANAGEMENT LLC
11/14
04:19 pm
alxo
Form SCHEDULE 13G/A ALX ONCOLOGY HOLDINGS Filed by: TANG CAPITAL MANAGEMENT LLC
High
Report
Form SCHEDULE 13G/A ALX ONCOLOGY HOLDINGS Filed by: TANG CAPITAL MANAGEMENT LLC
11/7
04:02 pm
alxo
Form 10-Q ALX ONCOLOGY HOLDINGS For: Sep 30
Medium
Report
Form 10-Q ALX ONCOLOGY HOLDINGS For: Sep 30
11/7
08:17 am
alxo
Form 8-K ALX ONCOLOGY HOLDINGS For: Nov 07
High
Report
Form 8-K ALX ONCOLOGY HOLDINGS For: Nov 07
10/22
04:28 pm
alxo
Form SCHEDULE 13G/A ALX ONCOLOGY HOLDINGS Filed by: MILLENNIUM MANAGEMENT LLC
Medium
Report
Form SCHEDULE 13G/A ALX ONCOLOGY HOLDINGS Filed by: MILLENNIUM MANAGEMENT LLC
10/16
04:01 pm
alxo
Form 4 ALX ONCOLOGY HOLDINGS For: Oct 14 Filed by: Pinto Shelly
Medium
Report
Form 4 ALX ONCOLOGY HOLDINGS For: Oct 14 Filed by: Pinto Shelly
10/16
04:01 pm
alxo
Form 4 ALX ONCOLOGY HOLDINGS For: Oct 14 Filed by: Lettmann Jason
Medium
Report
Form 4 ALX ONCOLOGY HOLDINGS For: Oct 14 Filed by: Lettmann Jason
10/16
04:01 pm
alxo
Form 4 ALX ONCOLOGY HOLDINGS For: Oct 14 Filed by: Shantharam Harish
Medium
Report
Form 4 ALX ONCOLOGY HOLDINGS For: Oct 14 Filed by: Shantharam Harish
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: